
European Journal of Inorganic Chemistry p. 2968 - 2979 (2017)
Update date:2022-08-05
Topics:
Yadav, Sangeeta
Singh, Harkesh B.
Butcher, Ray J.
The reactivities of the monodentate selone LSe (L = 1,3-dibutylbenzimidazol-2-ylidene; 10a), the bidentate pyridine-functionalized selone L′Se (L′ = 1-pyridyl-3-butylimidazol-2-ylidene; 10b) and the multidentate ether-functionalized selone L′′Se {L′′ = 1,3-bis[2-(2-methoxyethoxy)ethyl]benzimidazol-2-ylidene; 10c} with soft transition-metal halides (PdX2, PtX2, ZnX2, CdX2 and HgX2; X = Cl, Br, I) are probed. Compounds 10a and 10c react with metal halides to give complexes of the type [Cu2(μ-X)2(LSe)2] (X = Br, I; 11, 12), [MX2(LSe)2] (13–22) or [M2X2(μ-X)2(L′′Se)2] (X = Cl, Br, I; 26–32), whereas 10b and HgX2 (X = Cl, Br, I) form 1:1 complexes HgX2(L′Se) (21–23), in which the pyridine moiety coordinates to the metal centre to form a six-membered chelate. The reactivity of 10a was compared with those of triphenylphosphine and triethylamine. The reaction of 10c with molecular iodine yields the diiodoselone L′′SeI2 (35), which disproportionates to give the selone adduct of the iodonium ion, [(L′′Se)2I]+I3– (36). The reactions of LSeX2 [X = Cl (34a), Br (34b), I (34c)] with organotellurium compounds, namely, tellone LTe (10d) and diphenyl telluride (37), afford the dihalotellones LTeX2 [X = Cl (38a), Br (38b), I (38c)] and Ph2TeX2 [X = Cl (39a), Br (39b), I (39c)], respectively. The oxidizing properties of LSeX2 (34a–34c) were investigated with rare-earth metals.
View MoreContact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Shanghai Zhihua ChemTech Co., Ltd.
Contact:+86-13774313779
Address:Room 817 Suite B 3333 Shenjiang Road
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
website:https://www.finerchem.com
Contact:+86-531-88989536
Address:New Material Industrial Park, Jinan City, China
Contact:410-273-7300; 800-221-3953
Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
Doi:10.1016/S0040-4020(01)86599-6
(1992)Doi:10.1007/BF00473953
(1992)Doi:10.1021/acs.joc.6b02713
(2017)Doi:10.1021/jo9915473
(2000)Doi:10.1021/jm00329a019
(1965)Doi:10.1007/BF00629836
(1991)